Clinical Trial

Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this randomized phase II study is a formal comparison of radiotherapy versus trans-oral surgery as the primary treatment of HPV-negative patients with early-stage oropharyngeal carcinoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-01-06.
Status change: Not Yet Recruiting → Recruiting 2020-09-02
Trial Details
NCT Number NCT04220749
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions Head and Neck Cancer, Oropharyngeal Squamous Cell Carcinoma
Enrollment 68 participants
Start Date 2020-06-25
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2020-09-04